Subject: PZOO Up Double Digit % on Big News

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
PZOO Up Double Digit % on Big News
Hot Stock to WatchHot Stock to Watch

Company: Pazoo Inc. (OTCQB: PZOO)

End of Day:

Price: 0.0095

Change (%): + 0.002 (26.67)

Volume: 20,705,921
PZOO Chart

Pazoo Wholly Owned Subsidiary, Harris Lee, LLC. Signs Definitive Agreement to be the Exclusive Marijuana Testing Laboratory in the State of Oregon for Steep Hill Labs, Inc.

WHIPPANY, N.J., March 11, 2015 (GLOBE NEWSWIRE) - Pazoo, Inc. (OTCQB:PZOO) (German WKN#:A1J3DK) is pleased to report that wholly owned Subsidiary, Harris Lee, LLC., a company created to open and operate best-in-class marijuana testing labs throughout the USA has entered into a License Agreement with Steep Hill Labs, Inc. This agreement makes Harris Lee the exclusive Marijuana testing lab for Steep Hill Labs, Inc. in the state of Oregon.

Steep Hill Labs, Inc. is the unquestioned world-wide leader in marijuana testing and research. Harris Lee paid a license fee to Steep Hill Labs, Inc. for the exclusive rights and then will pay a royalty fee for each test conducted in the Oregon Laboratory once up and operational. As part of this agreement Harris Lee has also obtained the right of first refusal to become the exclusive testing lab for Steep Hill Labs, Inc. in other states.

Continue Reading

Top PerformerYesterday's Top Performer


End of Day:

Price: 0.231

Change (%): - 0.094 (28.92)

Volume: 2,980
UVND Chart

About U-Vend, Inc.

U-Vend, Inc. is headquartered in Santa Monica, CA, with additional locations in Stoney Creek, Ontario Canada, Chicago, IL., Los Angeles, CA. and Las Vegas, NV. U-Vend develops, distributes and markets various next-generation, self-serve electronic kiosks in a variety of retail locations in North America. The Company owns and operates kiosks and has partnered with numerous national consumer product companies to deliver new and unique customer retail experiences in an automated setting.

Company Information Sheet

Other Small Cap News

Company: EastGate Biotech Corp. (OTCBB: ETBI)

EastGate Biotech Receives Purchase Order from its Canadian Distributor for Nutraceutical Products

SALT LAKE CITY and TORONTO, March 11, 2015 /PRNewswire/ -- EastGate Biotech Corp. (OTCBB: ETBI), an emerging pharmaceutical company aimed at utilizing drug delivery innovations in the development of improved novel formulations and alternative dosage forms of existing biologically active molecules has received a purchase order from its newly-engaged Canadian distributor Preferred Nutrition. The company has already received a cash deposit for this initial order.

The first order by Preferred Nutrition was placed for E-drops - the Company's natural and herbal alternative that helps the body to rid of UTI infections painlessly and effectively without side effects of antibiotics or synthetic drugs.

Continue Reading

Company: Epazz, Inc. (OTCQB: EPAZ)

Epazz Confirms Convertible Note Is Paid Off and Sold Off

No Reverse Stock Split

CHICAGO, IL--(Marketwired - March 11, 2015) - Epazz, Inc. (OTCQB: EPAZ), a leading provider of cloud based business software solutions, announced today that a convertible note which caused the price to drop dramatically has been paid off. The company has not received and is not seeking any additional financing from the note holder. The company will not do a reverse stock split unless the company needs to do so to qualify for a national stock exchange.

Epazz, Inc.'s CEO, Shaun Passley, Ph.D., said, "The convertible note is gone. The note holder has no more shares and the note is paid off. We will not work with them again. We expect with our recent efforts that were done so far this year that the odds are good at this point that we will see a bounce back from an oversold condition and we are hoping will see the stock get back to a more reasonable valuation."

Continue Reading

Company: Nano Labs Corp. (Pink Sheets: CTLE)

Nano Labs Announces Joint Venture Agreement With the ET3M Group

Joint Venture Collaboration Agreement for the Research and Development, Manufacturing, Distribution and Marketing of ET3M's Technology and Products

DETROIT, MI--(Marketwired - Mar 11, 2015) - Nano Labs Corp. (OTC PINK: CTLE) is pleased to announce today the Company has entered into a Joint Venture Agreement with the ET3M Group (ET3M) to launch a Market Development Program (MDP) to develop, design, manufacture and sell applications of the ET3M Group's technology.

The ET3M lab is a world leader in the field of applied physics and a developer of avant-garde concepts in high energy physics with practical applications related to recently discovered concepts and properties placed at the frontier of electrodynamics.

Continue Reading

Market News

By Scott Krisiloff: SKrisiloff's Tumblr

Next up for stocks: Bubble or Bust.

Dear Investors,

Last fall I wrote about how economic expansions can often take place in three phases.

The first phase is the recovery phase. In that phase, investors have just been burned by a bear market and therefore still don’t really believe that the markets and economy are recovering. Sentiment in that phase is characterized by cynicism and fear and valuations are usually low. In the current bull market, this phase lasted from 2009-2011.

The second phase is the growth phase. As memories of the bear market fade away, investors begin to feel more comfortable committing capital to markets. By the end of the second phase, valuations usually rise to high but still somewhat rational levels and sentiment improves to become more optimistic. In the current bull market, this phase lasted from 2012-2014.

Continue Reading

By Fred Imbert:

Cramer: Currencies are moving too fast

Investors should not be overly worried that the dollar and the euro are flirting with parity, but rather with the speed at which they are doing so, CNBC's Jim Cramer said Wednesday.

"I think people forget that we've been there before and it was OK. There was also a really long period where we debased the dollar," he said on CNBC's "Squawk on the Street." But "even though this is historically OK, it's the velocity [that's concerning]. If we would see any good news coming out of Europe in terms of a strong economy... we would break the velocity."

The euro breached below $1.06 against the dollar for the first time in about 12 years on Wednesday, while the dollar index rose to another multiyear high when it reached 99.50. The euro zone currency traded at $1.05801 shortly before the U.S. markets began Wednesday's trading session.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks